This site is intended for healthcare professionals
Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators
Antiplatelet therapy in ACS: Choices and Controversies

ACS Patient Focus

Read time: 40 mins
Last updated:20th May 2022
Published:21st Apr 2022

Sharpen your knowledge of patient management options for patients on antiplatelet therapy. Watch our short and informative videos featuring experts Professor Robert Storey and Dr Marc P Bonaca and learn:  

  • When pretreatment with a P2Y12 inhibitor before angiography is recommended
  • How type 2 diabetes impacts risk and treatment choice in acute coronary syndrome
  • Strategies for de-escalation of dual antiplatelet therapy

Patient focus video: NSTE-ACS

Watch this insightful patient focus video and learn from experts Professor Robert Storey and Dr Marc P Bonaca as they discuss strategies for managing older patients with non-ST elevation-acute coronary syndrome and comorbid diabetes. Find out how diabetes impacts the risk of developing acute coronary syndrome, and discover considerations to take when dual antiplatelet therapy de-escalation is indicated.

What have you learned about antiplatelet therapy in non-ST elevation-acute coronary syndrome? Now that you have watched the patient case study discussion, test your knowledge by taking this quiz.

Patient focus video: STEMI

Follow Professor Robert Storey and Dr Marc P Bonaca as they discuss the optimal treatment strategy for a male patient aged 68 years with inferior ST-segment elevation myocardial infarction (STEMI) who is at high risk of bleeding and ischaemia. In this case study, they discuss the pivotal clinical trials and how that evidence informs the treatment considerations.

Test your knowledge of antiplatelet therapy in ST-segment elevation myocardial infarction (STEMI). Take this five-question quiz based on the STEMI patient focus case study.

Welcome: